The following is a summary of “Recognition of glycine versus non-glycine citrulline motifs dictates the HLA class II ...
Greenwich LifeSciences (GLSI) stock surges 23% premarket after promising Phase 3 results for GLSI-100, a breast cancer ...
In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...
The two-time Olympic gold medallist is among 36 per cent of people with the condition who are clinically diagnosed ...
Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for ...
Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term ...
For roughly one in every hundred people, food containing even the smallest amounts of gluten can deliver a gutful of hurt and ...
Culton and Myers stressed the importance of raising awareness about these rare diseases and of getting more physicians and ...
Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results